SafeSource plans to produce more than two billion gloves per annum by January 2024.
This move will help the company create value for all of its stakeholders.
The Optimum TAV demonstrated pre-clinical durability of up to 24 years with reduced calcification.
The Filtek Matrix is the newest addition to the company’s restorative solutions portfolio.
As against current MIS technologies, the TELIGEN System could be efficient and cost-effective for hospitals.
Get industry leading news, data and analysis delivered to your inbox
CZT enables the reduction of scan times and the decrease of radiation dose to the patient.
The test uses lesion swap specimen and RT-PCR testing to detect Monkeypox.
The approval has been granted for the OmniTom Elite, BodyTom Elite, and CereTom Elite mobile CT systems.
Adaptive’s work with Epic will start immediately as the clonoSEQ integration is expected to go live next year.
Phagenesis is currently involved in the preparation of a targeted launch of the neurostimulation system in the US.